A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC
The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC...
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
Currently, in clinical practice there has been no standardization in the number of injections a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing use of this tr...
Top Cities for Overactive Bladder Clinical Trials
Overactive Bladder clinical trials are recruiting across 8 cities. Here are the cities with the most active studies:
About Overactive Bladder
Overactive bladder (OAB) is a condition causing a sudden, frequent urge to urinate that may be difficult to control. It affects millions of adults and can significantly impact quality of life. Treatment includes behavioral therapy, medications (anticholinergics), and nerve stimulation.
Clinical trials are advancing new treatments for overactive bladder. Currently, 2 studies are recruiting a combined 145 participants across the United States. Research is being conducted by 2 organizations including Urovant Sciences GmbH, University of South Florida.
2026 Overactive Bladder Research Landscape
As of March 2026, the overactive bladder clinical trial landscape includes 2 actively recruiting studies across 8 cities in the United States. These studies are collectively seeking 145 participants, with an average enrollment target of 73 per study.
Research is being led by 2 different organizations, including Urovant Sciences GmbH, University of South Florida.
Geographically, overactive bladder trials are most concentrated in Orange, California (1 trial); Jacksonville, Florida (1 trial); Wichita, Kansas (1 trial); New Orleans, Louisiana (1 trial); Albany, New York (1 trial) and 3 other cities.
Featured Overactive Bladder Studies
Highlighted recruiting studies for overactive bladder, selected by enrollment size and research scope.
A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC
The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
Currently, in clinical practice there has been no standardization in the number of injections a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing use of this treatment modality, the aim of this study is to compare outcomes for patients given a 100 unit dose of onabotulinumtoxin A split into 5 as compared to 20 injections for the treatment of overactive bladd...
Frequently Asked Questions About Overactive Bladder Clinical Trials
Are there overactive bladder clinical trials near me?
Yes, there are 2 overactive bladder clinical trials currently recruiting across 8+ cities in the United States, including Orange, California; Jacksonville, Florida; Wichita, Kansas. Browse the studies above to find one at a location convenient for you.
How do I join a overactive bladder clinical trial?
To join a overactive bladder clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are overactive bladder clinical trials free?
Yes, participation in overactive bladder clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of overactive bladder treatments are being studied?
Current overactive bladder clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in overactive bladder clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov